Literature DB >> 23651423

One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice.

Paolo Capogrosso1, Michele Colicchia, Eugenio Ventimiglia, Giulia Castagna, Maria Chiara Clementi, Nazareno Suardi, Fabio Castiglione, Alberto Briganti, Francesco Cantiello, Rocco Damiano, Francesco Montorsi, Andrea Salonia.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) is a common complaint in men over 40 years of age, and prevalence rates increase throughout the aging period. Prevalence and risk factors of ED among young men have been scantly analyzed. AIM: Assessing sociodemographic and clinical characteristics of young men (defined as ≤ 40 years) seeking first medical help for new onset ED as their primary sexual disorder.
METHODS: Complete sociodemographic and clinical data from 439 consecutive patients were analyzed. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Patients completed the International Index of Erectile Function (IIEF). MAIN OUTCOME MEASURE: Descriptive statistics tested sociodemographic and clinical differences between ED patients ≤ 40 years and >40 years.
RESULTS: New onset ED as the primary disorder was found in 114 (26%) men ≤ 40 years (mean [standard deviation [SD]] age: 32.4 [6.0]; range: 17-40 years). Patients ≤ 40 years had a lower rate of comorbid conditions (CCI = 0 in 90.4% vs. 58.3%; χ(2) , 39.12; P < 0.001), a lower mean body mass index value (P = 0.005), and a higher mean circulating total testosterone level (P = 0.005) as compared with those >40 years. Younger ED patients more frequently showed habit of cigarette smoking and use of illicit drug, as compared with older men (all P ≤ 0.02). Premature ejaculation was more comorbid in younger men, whereas Peyronie's disease was prevalent in the older group (all P = 0.03). At IIEF, severe ED rates were found in 48.8% younger men and 40% older men, respectively (P > 0.05). Similarly, rates of mild, mild-to-moderate, and moderate ED were not significantly different between the two groups.
CONCLUSIONS: This exploratory analysis showed that one in four patients seeking first medical help for new onset ED was younger than 40 years. Almost half of the young men suffered from severe ED, with comparable rates in older patients. Overall, younger men differed from older individuals in terms of both clinical and sociodemographic parameters.
© 2013 International Society for Sexual Medicine.

Entities:  

Keywords:  Age; Clinical Practice; Comorbidities; Elderly; Erectile Dysfunction; Health Status; International Index of Erectile Function; Risk Factors; Young

Mesh:

Substances:

Year:  2013        PMID: 23651423     DOI: 10.1111/jsm.12179

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  24 in total

1.  Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors.

Authors:  W-K Tsai; B-P Jiann
Journal:  Int J Impot Res       Date:  2014-01-23       Impact factor: 2.896

2.  Brachial artery flow-mediated dilatation and carotid intima-media thickness in young ED patients with insulin resistance.

Authors:  S-F Chen; F-J Yao; X-Z Sun; R-P Wu; Y-P Huang; F-F Zheng; Q-Y Yang; D-Y Han; M-Q Xie; M Ding; Y Zhang; G-H Liu; C-H Deng
Journal:  Int J Impot Res       Date:  2016-08-04       Impact factor: 2.896

3.  Trends in reported male sexual dysfunction over the past decade: an evolving landscape.

Authors:  Edoardo Pozzi; Paolo Capogrosso; Luca Boeri; Walter Cazzaniga; Rayan Matloob; Eugenio Ventimiglia; Davide Oreggia; Nicolò Schifano; Luigi Candela; Costantino Abbate; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2020-07-01       Impact factor: 2.896

4.  Pathological Roles of Reactive Oxygen Species in Male Reproduction.

Authors:  Saptaparna Chakraborty; Shubhadeep Roychoudhury
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  The relationship between the gut microbiota, benign prostatic hyperplasia, and erectile dysfunction.

Authors:  Giorgio Ivan Russo; Dafne Bongiorno; Carmelo Bonomo; Nicolò Musso; Stefania Stefani; Ioannis Sokolakis; Georgios Hatzichristodoulou; Marco Falcone; Tommaso Cai; Francesco Smarrazzo; Paolo Verze
Journal:  Int J Impot Res       Date:  2022-04-13       Impact factor: 2.896

6.  Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.

Authors:  V Favilla; G I Russo; G Reale; S Leone; T Castelli; S La Vignera; R A Condorelli; A E Calogero; S Cimino; G Morgia
Journal:  Int J Impot Res       Date:  2015-07-30       Impact factor: 2.896

7.  Results from an online survey investigating ED patients' insights and treatment expectations.

Authors:  A Burri; H Porst
Journal:  Int J Impot Res       Date:  2015-07-30       Impact factor: 2.896

Review 8.  Erectile dysfunction.

Authors:  Faysal A Yafi; Lawrence Jenkins; Maarten Albersen; Giovanni Corona; Andrea M Isidori; Shari Goldfarb; Mario Maggi; Christian J Nelson; Sharon Parish; Andrea Salonia; Ronny Tan; John P Mulhall; Wayne J G Hellstrom
Journal:  Nat Rev Dis Primers       Date:  2016-02-04       Impact factor: 52.329

9.  Erectile Dysfunction in a Sample of Sexually Active Young Adult Men from a U.S. Cohort: Demographic, Metabolic and Mental Health Correlates.

Authors:  Jerel P Calzo; S Bryn Austin; Brittany M Charlton; Stacey A Missmer; Martin Kathrins; Audrey J Gaskins; Jorge E Chavarro
Journal:  J Urol       Date:  2020-09-16       Impact factor: 7.450

10.  Asexuality development among middle aged and older men.

Authors:  Yan-Ping Huang; Bin Chen; Ping Ping; Hong-Xiang Wang; Kai Hu; Hao Yang; Tao Zhang; Tan Feng; Yan Jin; Yin-Fa Han; Yi-Xin Wang; Yi-Ran Huang
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.